Mobile Integrated Health and Post–Hospital Discharge Heart Failure Care - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Post-Discharge Heart Failure Management through Mobile Integrated Health Services

  • By

  • Meghan Reading Turchioe

  • Melani Ellison

  • Leah Shafran Topaz

  • Christina McGinnis

  • Jacky Choi

  • Yihong Zhao

  • Stacey Dai

  • Parag Goyal

  • Rohit Mukherjee

  • Erik Blutinger

  • Roland C. Merchant

  • Brock Daniels

  • Ruth Masterson Creber

  • August 21, 2026

Share

  • 1

    Mobile integrated health (MIH) provides patient-centered, nonemergency services in home or community settings through interdisciplinary teams.

  • 2

    MIH programs in the US have the potential to reduce emergency department visits, hospital readmissions, and healthcare costs while enhancing satisfaction.

  • 3

    The MIGHTy-Heart trial evaluated MIH's effectiveness in managing heart failure patients post-discharge, comparing it to traditional care coordination.

  • 4

    The RE-AIM framework was utilized to assess MIH intervention across reach, effectiveness, adoption, implementation, and maintenance dimensions.

  • 5

    Qualitative data from interviews with patients and healthcare professionals informed the evaluation of MIH program adoption and sustainability.

Original Source(s)

Mobile Integrated Health and Post–Hospital Discharge Heart Failure Care

  • by Meghan Reading Turchioe, Melani Ellison, Leah Shafran Topaz, Christina McGinnis, Jacky Choi, Yihong Zhao, Stacey Dai, Parag Goyal, Rohit Mukherjee, Erik Blutinger, Roland C. Merchant, Brock Daniels, Ruth Masterson Creber

  • August 21, 2026

Related Content

Exercise rejuvenates the “muscle-heart” crosstalk: skeletal muscle-derived exosomal miRNAs in cardiac aging

Predictive value of the serum sodium to log(D-dimer) ratio for the risk of all-cause death in patients with chronic heart failure with different ejection fractions

Efficacy and safety of quadruple therapy versus triple therapy in patients with heart failure with preserved ejection fraction: a propensity score-matched real-world study